Gaudium IVF And Women Health Limited
Bookbuilding IPO · NSE, BSE
- Price band
- ₹75 - ₹79
- Lot size
- 189 shares
- Issue amount
- ₹165 cr
- Total subscription
- 7.27×
- Opens
- 20 Feb 2026
- Closes
- 24 Feb 2026
- Allotment
- 25 Feb 2026
- Listing
- 27 Feb 2026
Offer at a glance
Issue overview
- Issue size
- 2,08,86,200 shares
- Face value
- ₹5 per share
- Minimum investment
- ₹14,175
- Fresh issue
- ₹90 cr
- Offer for sale
- ₹75 cr
- Registrar
- Bigshare Services Private Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹14,931
- Issue type
- Bookbuilding IPO
- Shares before issue
- 6,13,94,384
- Shares after issue
- 7,27,86,884
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 189 | ₹14,931 |
| sHNI | 14 | 2,646 | ₹2,09,034 |
| bHNI | 67 | 12,663 | ₹10,00,377 |
Share reservation
Subscription & GMP
Subscription by category
Reported 24 Feb 2026
GMP history
Day-wise demand
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| RETAIL | 38,678 | 2,40,713 |
| HNIs(10L +) | 789 | 1,984 |
| HNIs (2-10L) | 395 | 6,296 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 33 | 53.61 |
| RETAIL | 57.75 | 438.79 |
| HNIs 2+ | 8.25 | 137.98 |
| HNIs 10+ | 16.5 | 209.79 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Sep-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| EPS | 2.04 | 3.12 | 1.68 | 2.2 |
| ROE | 21.25 | 41.31 | 38.23 | 59.51 |
| ROCE | 21.03 | 39.37 | 38.74 | 54.4 |
| RONW | 0 | 0 | 0 | 0 |
| PRE IPO(PE) | 0 | 25.36 | 0 | 0 |
| POST IPO(PE) | 22.99 | 0 | 0 | 0 |
Values and labels as reported in the issue data.
Peer comparison
| Company | P/E(X) | CMP* (₹) | Face value (₹) | NAV/Share (₹) | RONW(%) | EPS (Basic) (₹) |
|---|---|---|---|---|---|---|
| Progyny Inc | 41.56 | 2099.98 | 0.0001 | 394.20 | 12.90 | 50.52 |
| Inspire IVF Public Company Limited | 11.43 | 1.99 | 0.05 | 4.34 | 3.97 | 3.97 |
| Gaudium IVF and Women Health Limited | 25.36 | 79.00 | 5.00 | 7.54 | 41.71 | 3.12 |
Company information
Company profile
Founded in March 2015, Gaudium IVF and Women Health Limited specializes in In Vitro Fertilization (IVF) and women’s healthcare services across India, operating through a hub-and-spoke model with seven hubs and twenty-eight spokes. The company collaborates with Infertility Experts to promote awareness of Assisted Reproductive Technology (ART) and IVF treatments. Serving patients from countries like Canada, the UK, the USA, Kenya, South Africa, and Oman, Gaudium has centres in key cities such as Delhi, Mumbai, Ludhiana, Srinagar, Patna, and Bangalore. It offers advanced fertility treatments including IVF, ICSI, IUI, ovulation induction, and male infertility solutions, along with specialized care for PCOD/PCOS, endometriosis, and high-risk pregnancies.
Strengths
- Patient-Centric Care: Focuses on personalized fertility and women’s healthcare solutions.
- Experienced Medical Team: Skilled fertility specialists drive strong clinical outcomes.
- Advanced Lab Infrastructure: Equipped with next-gen INTEGRA Ti technology for high-precision procedures.
Risk factors
- Healthcare & Legal Risk: Fertility treatments face strict medical, regulatory, and reputational scrutiny.
- Dependence on Medical Professionals: Difficulty in attracting or retaining specialists may affect performance.
- Brand Reputation Risk: Negative publicity or allegations could impact patient trust and business growth.
Promoters
Dr. Manika Khanna
Dr. Peeyush Khanna
Vishad Khanna
Registrar & documents
Lead manager
Sarthi Capital Advisors Private Limited
Registrar & contacts
Bigshare Services Private Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
B1/51, Janak Puri, B-1, New Delhi, New Delhi, 110058
011-4885 8585
[email protected]Company website ↗Frequently Asked Questions
What is Gaudium IVF And Women Health IPO GMP today?
As of today, Gaudium IVF And Women Health IPO Grey Market Premium (GMP) is reported at −₹2 per share. Based on the upper price band of ₹79, the estimated listing price is ₹77 (-2.5% expected discount). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.
What is the lot size and minimum investment for Gaudium IVF And Women Health IPO?
The minimum bid lot size for Gaudium IVF And Women Health IPO is 189 shares. At the cut-off price of ₹79 per share, retail investors need a minimum application amount of ₹14,931 per lot. Retail applicants can apply for a maximum of 13 lots (up to ₹2,00,000).
When will Gaudium IVF And Women Health IPO allotment status be announced?
The allotment status for Gaudium IVF And Women Health IPO is scheduled to be finalized on 25 Feb 2026. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Bigshare Services Private Limited's official portal or via BSE/NSE allotment portals.
How can I check Gaudium IVF And Women Health IPO allotment status online by PAN?
To check Gaudium IVF And Women Health IPO allotment status: 1) Visit the registrar portal (Bigshare Services Private Limited) or the BSE IPO allotment page. 2) Select 'Gaudium IVF And Women Health Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.